CYTH
Cyclo Therapeutics (CYTH)
$66
About Cyclo Therapeutics (CYTH)
Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.
Details
Daily high
$0.68
Daily low
$0.62
Price at open
$0.63
52 Week High
$2.12
52 Week Low
$0.55
Market cap
17.8M
Dividend yield
0.00%
Volume
54,563
Avg. volume
62,241
P/E ratio
-.70
Cyclo Therapeutics News
Details
Daily high
$0.68
Daily low
$0.62
Price at open
$0.63
52 Week High
$2.12
52 Week Low
$0.55
Market cap
17.8M
Dividend yield
0.00%
Volume
54,563
Avg. volume
62,241
P/E ratio
-.70